Report Detail

Pharma & Healthcare Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4588055
  • |
  • 21 May, 2024
  • |
  • Global
  • |
  • 98 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market size was valued at US$ 316 million in 2023 and is forecast to a readjusted size of USD 614 million by 2030 with a CAGR of 10.6% during review period.
This report is a detailed and comprehensive analysis for global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Grade Eicosapentaenoic Acid (EPA)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KD Pharma, Nippon Suisan Kaisha, Bizen Chemical, AK Biopharm, Maruha Nichiro, Croda Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity 96.5%
Purity 99%
Market segment by Application
Cardiovascular Disease Drugs
Hypolipidemic Drugs
Major players covered
KD Pharma
Nippon Suisan Kaisha
Bizen Chemical
AK Biopharm
Maruha Nichiro
Croda Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Grade Eicosapentaenoic Acid (EPA) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Grade Eicosapentaenoic Acid (EPA), with price, sales quantity, revenue, and global market share of Pharmaceutical Grade Eicosapentaenoic Acid (EPA) from 2019 to 2024.
Chapter 3, the Pharmaceutical Grade Eicosapentaenoic Acid (EPA) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Grade Eicosapentaenoic Acid (EPA) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Grade Eicosapentaenoic Acid (EPA).
Chapter 14 and 15, to describe Pharmaceutical Grade Eicosapentaenoic Acid (EPA) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Purity 96.5%
    • 1.3.3 Purity 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Cardiovascular Disease Drugs
    • 1.4.3 Hypolipidemic Drugs
  • 1.5 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market Size & Forecast
    • 1.5.1 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity (2019-2030)
    • 1.5.3 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 KD Pharma
    • 2.1.1 KD Pharma Details
    • 2.1.2 KD Pharma Major Business
    • 2.1.3 KD Pharma Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Product and Services
    • 2.1.4 KD Pharma Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 KD Pharma Recent Developments/Updates
  • 2.2 Nippon Suisan Kaisha
    • 2.2.1 Nippon Suisan Kaisha Details
    • 2.2.2 Nippon Suisan Kaisha Major Business
    • 2.2.3 Nippon Suisan Kaisha Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Product and Services
    • 2.2.4 Nippon Suisan Kaisha Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Nippon Suisan Kaisha Recent Developments/Updates
  • 2.3 Bizen Chemical
    • 2.3.1 Bizen Chemical Details
    • 2.3.2 Bizen Chemical Major Business
    • 2.3.3 Bizen Chemical Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Product and Services
    • 2.3.4 Bizen Chemical Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Bizen Chemical Recent Developments/Updates
  • 2.4 AK Biopharm
    • 2.4.1 AK Biopharm Details
    • 2.4.2 AK Biopharm Major Business
    • 2.4.3 AK Biopharm Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Product and Services
    • 2.4.4 AK Biopharm Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 AK Biopharm Recent Developments/Updates
  • 2.5 Maruha Nichiro
    • 2.5.1 Maruha Nichiro Details
    • 2.5.2 Maruha Nichiro Major Business
    • 2.5.3 Maruha Nichiro Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Product and Services
    • 2.5.4 Maruha Nichiro Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Maruha Nichiro Recent Developments/Updates
  • 2.6 Croda Pharma
    • 2.6.1 Croda Pharma Details
    • 2.6.2 Croda Pharma Major Business
    • 2.6.3 Croda Pharma Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Product and Services
    • 2.6.4 Croda Pharma Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Croda Pharma Recent Developments/Updates

3 Competitive Environment: Pharmaceutical Grade Eicosapentaenoic Acid (EPA) by Manufacturer

  • 3.1 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Revenue by Manufacturer (2019-2024)
  • 3.3 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Pharmaceutical Grade Eicosapentaenoic Acid (EPA) by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Manufacturer Market Share in 2023
  • 3.5 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market: Overall Company Footprint Analysis
    • 3.5.1 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market: Region Footprint
    • 3.5.2 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market: Company Product Type Footprint
    • 3.5.3 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market Size by Region
    • 4.1.1 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value by Region (2019-2030)
    • 4.1.3 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Average Price by Region (2019-2030)
  • 4.2 North America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value (2019-2030)
  • 4.3 Europe Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value (2019-2030)
  • 4.5 South America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Type (2019-2030)
  • 5.2 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value by Type (2019-2030)
  • 5.3 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Application (2019-2030)
  • 6.2 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value by Application (2019-2030)
  • 6.3 Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Type (2019-2030)
  • 7.2 North America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Application (2019-2030)
  • 7.3 North America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market Size by Country
    • 7.3.1 North America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Type (2019-2030)
  • 8.2 Europe Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Application (2019-2030)
  • 8.3 Europe Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market Size by Country
    • 8.3.1 Europe Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market Size by Region
    • 9.3.1 Asia-Pacific Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Type (2019-2030)
  • 10.2 South America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Application (2019-2030)
  • 10.3 South America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market Size by Country
    • 10.3.1 South America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market Size by Country
    • 11.3.1 Middle East & Africa Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market Drivers
  • 12.2 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market Restraints
  • 12.3 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pharmaceutical Grade Eicosapentaenoic Acid (EPA) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pharmaceutical Grade Eicosapentaenoic Acid (EPA)
  • 13.3 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Typical Distributors
  • 14.3 Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pharmaceutical Grade Eicosapentaenoic Acid (EPA). Industry analysis & Market Report on Pharmaceutical Grade Eicosapentaenoic Acid (EPA) is a syndicated market report, published as Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,703.96
    4,055.94
    5,407.92
    3,208.56
    4,812.84
    6,417.12
    534,006.00
    801,009.00
    1,068,012.00
    291,484.80
    437,227.20
    582,969.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report